Acta diabetologica
Muscle loss and GLP-1R agonists use.
Giada Rossi, Loredana Bucciarelli, Chyrell-Lyn Mananguite, Matteo Giovarelli, Paolo Fiorina
Published: 202510.1007/s00592-025-02611-2
Abstract
Skeletal muscle wasting is a major yet often overlooked determinant of adverse outcomes in diabetes mellitus and obesity. Loss of muscle mass and strength not only impairs mobility and quality of life, but also worsens insulin resistance, accelerates…
Preview only. Read the full abstract at the source